The American Medical Association is urging CMS to reopen a payment program exception before a March 31 deadline as a nationwide intravenous fluid shortage pummels the healthcare industry.  CMS has ...

Sangrur Hospital IV Fluid Reactions: "Mild reactions were reported today in Sangrur after the use of Glucose IV Fluid in ...

The corporation blamed the delay down on storms, IV fluid shortages, and sales staff leaving-related disturbances. Revenue ...

Punjab Health Minister said that the patients' condition was stable. Punjab Health Minister Dr Balbir Singh said that the ...

The American multinational will match the investment, with the scaled-up facility expected to increase IV fluid production from 60 million units a year to 80 million units from 2027. Health ...

A $20 million Federal Government investment is set to expand Australia’s largest and only onshore manufacturer of IV fluid.

Fifteen patients at the Civil Hospital in Sangrur suffered mild reactions after being administered intravenous glucose.

Stay informed with our live blog covering India’s latest in politics, economy, crime, and general news. Get real-time updates ...

Q4 2024 earnings insights—revenue growth, revamped sales strategies, and product expansions positioning for a 2025 breakthrough.

It will expand local IV fluid production by an additional minimum 20 million units, to 80 million units each year from 2027. Baxter has a production facility in western Sydney but struggled to ...

Punjab Health Minister Dr Balbir Singh said samples have been sent for urgent testing, and strict action will be taken in ...